More Post from the Author
- Climate Activists Exploit Jasper Wildfire Anniversary - ICJ did no Due Diligence says Friends of Science Society
- Broadridge Schedules Webcast and Conference Call to Review Fourth Quarter and Fiscal Year 2025 Results on August 5, 2025
- AveriSource announces availability of AI-Powered Modernization Platform in the new AWS Marketplace AI Agents and Tools category
- OysterLink Reports Surge in Controversial Restaurant Fee Talks
- PRIVACY ALERT: House of Dior Under Investigation for Data Breach of Customer Records
QuantalX Neuroscience Announces CE MDR Approval, Making Brain Health Assessment Available in the EU
Published on Wed 12 Feb 2025 8:06:42 UTC

The company announces CE MDR approval for its novel Delphi-MD neurodiagnosis medical device in preparation for EU commercialization, improving patients' clinical outcomes and well being while reducing healthcare systems and payors' financial burden.
NEW YORK, Feb. 12, 2025 /PRNewswire/ --QuantalX Neuroscience Ltd. is proud to announce that its groundbreaking brain health assessment device, the Delphi-MD, has received CE MDR approval, the European Union's certification under the new Medical Device Regulation (MDR). The CE MDR certification process sets a new benchmark for safety, efficacy, and quality in medical devices. This achievement underscores QuantalX's commitment to innovation and excellence in neurological care.
More Post from the Author
- Climate Activists Exploit Jasper Wildfire Anniversary - ICJ did no Due Diligence says Friends of Science Society
- Broadridge Schedules Webcast and Conference Call to Review Fourth Quarter and Fiscal Year 2025 Results on August 5, 2025
- AveriSource announces availability of AI-Powered Modernization Platform in the new AWS Marketplace AI Agents and Tools category
- OysterLink Reports Surge in Controversial Restaurant Fee Talks
- PRIVACY ALERT: House of Dior Under Investigation for Data Breach of Customer Records